Search Results

Potency of whole virus particle and split virion vaccines using dissolving microneedle against challenges of H1N1 and H5N1 influenza viruses in mice.

• Authors : Nakatsukasa A; Laboratory of Microbiology, Department of Disease Control, Graduate School of Veterinary Medicine, Hokkaido University, Sapporo 060-0818, Japan.; Kuruma K

Subjects: Influenza A Virus, H1N1 Subtype/Influenza A Virus, H1N1 Subtype/Influenza A Virus, H1N1 Subtype/*immunology ; Influenza A Virus, H5N1 Subtype/Influenza A Virus, H5N1 Subtype/Influenza A Virus, H5N1 Subtype/*immunology ; Influenza Vaccines/Influenza Vaccines/Influenza Vaccines/*administration & dosage

• Source: Vaccine [Vaccine] 2017 May 15; Vol. 35 (21), pp. 2855-2861. Date of Electronic Publication: 2017 Apr 18.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Agricola

Record details

Beta-defensin 2 enhances immunogenicity and protection of an adenovirus-based H5N1 influenza vaccine at an early time.

• Authors : Vemula SV; Department of Comparative Pathobiology, College of Veterinary Medicine, Purdue University, West Lafayette, IN 47907, USA; Bindley Bioscience Center, Purdue University, West Lafayette, IN, USA.

Subjects: Adjuvants, Immunologic/Adjuvants, Immunologic/Adjuvants, Immunologic/*administration & dosage ; Influenza A Virus, H5N1 Subtype/Influenza A Virus, H5N1 Subtype/Influenza A Virus, H5N1 Subtype/*immunology ; Influenza Vaccines/Influenza Vaccines/Influenza Vaccines/*immunology

• Source: Virus research [Virus Res] 2013 Dec 26; Vol. 178 (2), pp. 398-403. Date of Electronic Publication: 2013 Sep 17.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8410979 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Human antibodies that neutralize respiratory droplet transmissible H5N1 influenza viruses.

• Authors : Thornburg NJ; Nannemann DP; Blum DL

Subjects: Vaccination*; Antibodies, Neutralizing/Antibodies, Neutralizing/Antibodies, Neutralizing/*chemistry ; Antibodies, Viral/Antibodies, Viral/Antibodies, Viral/*chemistry

• Source: The Journal of clinical investigation [J Clin Invest] 2013 Oct; Vol. 123 (10), pp. 4405-9. Date of Electronic Publication: 2013 Sep 03.Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Print-Electronic Cited

Record details

H5N1 influenza vaccine formulated with AS03 A induces strong cross-reactive and polyfunctional CD4 T-cell responses.

• Authors : Moris P; GlaxoSmithKline Biologicals, Rixensart, Belgium.; van der Most R

Subjects: Adjuvants, Immunologic*/Adjuvants, Immunologic*/Adjuvants, Immunologic*/administration & dosage ; Immunity, Cellular* ; Influenza A Virus, H5N1 Subtype*/Influenza A Virus, H5N1 Subtype*/Influenza A Virus, H5N1 Subtype*/chemistry

• Source: Journal of clinical immunology [J Clin Immunol] 2011 Jun; Vol. 31 (3), pp. 443-54. Date of Electronic Publication: 2010 Dec 21.Publisher: Springer Country of Publication: Netherlands NLM ID: 8102137 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Superior protection provided by a single dose of MF59-adjuvanted whole inactivated H5N1 influenza vaccine in type 1 diabetic mice.

• Authors : Wu J; College of Life Sciences, Hunan Normal University, Changsha 410081, Hunan, China.; Wang F

Subjects: Adjuvants, Immunologic/Adjuvants, Immunologic/Adjuvants, Immunologic/*administration & dosage ; Diabetes Mellitus, Type 1/Diabetes Mellitus, Type 1/Diabetes Mellitus, Type 1/*immunology ; Influenza A Virus, H5N1 Subtype/Influenza A Virus, H5N1 Subtype/Influenza A Virus, H5N1 Subtype/*immunology

• Source: Archives of virology [Arch Virol] 2011 Mar; Vol. 156 (3), pp. 387-95. Date of Electronic Publication: 2010 Nov 26.Publisher: Springer-Verlag Country of Publication: Austria NLM ID: 7506870 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Vaccination with different M2e epitope densities confers partial protection against H5N1 influenza A virus challenge in chickens.

• Authors : Zhang X; Animal Influenza Laboratory of the Ministry of Agriculture, and State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, PR China.; Liu M

Subjects: Epitopes/Epitopes/Epitopes/*immunology ; Influenza A Virus, H5N1 Subtype/Influenza A Virus, H5N1 Subtype/Influenza A Virus, H5N1 Subtype/*immunology ; Influenza Vaccines/Influenza Vaccines/Influenza Vaccines/*immunology

• Source: Intervirology [Intervirology] 2011; Vol. 54 (5), pp. 290-9. Date of Electronic Publication: 2011 Jan 13.Publisher: Karger Country of Publication: Switzerland NLM ID: 0364265 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1423-0100

Record details

Feasibility of single-shot H5N1 influenza vaccine in ferrets, macaques and rabbits.

• Authors : Heldens JG; Nobilon Part of MSD Laboratories, W. de Körverstraat 35, 5830 AN Boxmeer, The Netherlands.; Glansbeek HL

Subjects: Influenza A Virus, H5N1 Subtype/Influenza A Virus, H5N1 Subtype/Influenza A Virus, H5N1 Subtype/*immunology ; Influenza Vaccines/Influenza Vaccines/Influenza Vaccines/*administration & dosage ; Influenza Vaccines/Influenza Vaccines/Influenza Vaccines/*immunology

• Source: Vaccine [Vaccine] 2010 Nov 29; Vol. 28 (51), pp. 8125-31. Date of Electronic Publication: 2010 Oct 13.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

A single immunization with CoVaccine HT-adjuvanted H5N1 influenza virus vaccine induces protective cellular and humoral immune responses in ferrets.

• Authors : Bodewes R; Department of Virology, Erasmus Medical Center, Dr Molewaterplein 50, PO Box 2040, 3000 CA Rotterdam, Netherlands.; Kreijtz JH

Subjects: Adjuvants, Immunologic/Adjuvants, Immunologic/Adjuvants, Immunologic/*administration & dosage ; Influenza A Virus, H5N1 Subtype/Influenza A Virus, H5N1 Subtype/Influenza A Virus, H5N1 Subtype/*immunology ; Influenza Vaccines/Influenza Vaccines/Influenza Vaccines/*immunology

• Source: Journal of virology [J Virol] 2010 Aug; Vol. 84 (16), pp. 7943-52. Date of Electronic Publication: 2010 Jun 02.Publisher: American Society For Microbiology Country of Publication: United States NLM ID: 0113724 Publication Model: Print-Electronic Cited Medium:

Record details

[DNA vaccination via in vivo electroporation can elicit specific immune response against highly pathogenic H5N1 influenza viral structural antigens in mice].

• Authors : Wang W; National Institute for Viral Disease Control and Prevention, China CDC, Beijing 100052, China.; Chen H

Subjects: Electroporation*; Antigens, Viral/Antigens, Viral/Antigens, Viral/*immunology ; Influenza A Virus, H5N1 Subtype/Influenza A Virus, H5N1 Subtype/Influenza A Virus, H5N1 Subtype/*immunology

• Source: Bing du xue bao = Chinese journal of virology [Bing Du Xue Bao] 2010 May; Vol. 26 (3), pp. 170-5.Publisher: Chung-Kuo Wei Sheng Wu Hsueh Hui Country of Publication: China NLM ID: 8803009 Publication Model: Print Cited Medium: Print ISSN:

Record details